Affiliation:
1. Parasitology and Mycology Department, Central Laboratory of Medical Analysis, Hassan II University Hospital, Sidi Mohamed Ben Abdellah, Fez, Morocco
2. MD, Parasitology and Mycology Department, Central Laboratory of Medical Analysis, Hassan II University Hospital, Sidi Mohamed Ben Abdellah, Fez, Morocco
3. PROF, Parasitology and Mycology Department, Central Laboratory of Medical Analysis, Hassan II University Hospital, Sidi Mohamed Ben Abdellah, Fez, Morocco
Abstract
Opportunistic fungal infections have a high morality rate, occurring most often in immunocompromised
subjects. We report the case of a 19-year-old girl who presented with progressively worsening dyspnea,
hypoxemia requiring oxygen supplementation with bilateral pulmonary cystic lesions, treated with antibiotics for a presumptive
diagnosis of pneumonia. The patient did not improve clinically. A diagnostic bronchoscopy was performed, which revealed
ndings consistent with pulmonary pneumocystis. The patient tested positive for HIV, and had a positive cryptococcal
antigenemia. She was put on treatment adapted to each fungal infection with a favorable evolution.
Subject
Insect Science,Ecology, Evolution, Behavior and Systematics,Infectious Diseases,Immunology and Allergy,Medicine (miscellaneous),Epidemiology,Molecular Biology,Biochemistry,Infectious Diseases,Pulmonary and Respiratory Medicine,Aerospace Engineering,Mechanical Engineering,Energy Engineering and Power Technology,Aerospace Engineering,Computer Networks and Communications,Software,Electrical and Electronic Engineering,Communication,Artificial Intelligence,Information Systems,Control and Systems Engineering,Software,Urban Studies,Sociology and Political Science,Development
Reference19 articles.
1. Mamoudou S, Bellaud G, Ana C, & Gilles P. Coinfection pulmonaire par pneumocystis jirovecii et pseudomonas aeruginosa au cours du SIDA : propos de deux cas. Pan Afr Med J. 2015 ; 21.
2. Ouédraogo SM, Ouedraogo M, Dagnan NS, Adom AH. Infections opportunistes au cours du Sida au CHU de Treichville. Mali Médical. 2007;22:26-28.
3. WHO. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2018
4. Meyer AC, Jacobson M. Asymptomatic cryptococcemia in resource-limited settings. Curr HIV/AIDS Rep. 2013;10(3):254–63.
5. Lawrence DS, Boyer-Chammard T, and Jarvis JN. Emerging concepts in HIV-associated cryptococcal meningitis. Curr Opin Infect Dis, 2018. 30(10): p. 0000000000000514